Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson’s Disease

9 Sept 2022

Abstract excerpt

Parkinson's disease (PD) is the second most common neurodegenerative movement disorder characterized by a progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Although a complex interplay of multiple environmental and genetic factors has been implicated, the etiology of neuronal death in PD remains unresolved. Various mechanisms of neuronal degeneration in PD have been proposed,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Genomics, phytochemicals, and oxidative stress
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36139853
DOI: 10.3390/antiox11091780

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson’s DiseasePMID 36139853Read ↗

Bach1 derepression is neuroprotective in a mouse model of Parkinson’s diseaseSemantic proximity Read ↗

Bach2 is a potent repressor of Nrf2-mediated antioxidant enzyme expression in dopaminergic neuronsSemantic proximity Read ↗

Activation of Nrf2 Neuroprotective Pathways for Treatment of Parkinson’s Disease: A State of Art ReviewSemantic proximity Read ↗

Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson's diseaseSemantic proximity Read ↗

The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative DiseasesSemantic proximity Read ↗

The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's DiseaseSemantic proximity Read ↗

Nrf2: a modulator of Parkinson’s disease?Semantic proximity Read ↗

FUNCTIONAL ANALYSIS OF BIPARTITE NRF2 ACTIVATORS THAT OVERCOME FEEDBACK REGULATION FOR AGE-RELATED CHRONIC DISEASESSemantic proximity Read ↗

Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease.Semantic proximity Read ↗

Targeting Nrf2-Mediated Gene Transcription by Extremely Potent Synthetic Triterpenoids Attenuate Dopaminergic Neurotoxicity in the MPTP Mouse Model of Parkinson's DiseaseSemantic proximity Read ↗

Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic ImplicationsSemantic proximity Read ↗

Role of the Transcription Factor Nrf2 in Parkinson’s Disease: New InsightsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.